ScreenerHero
BIOPORBioPorto A/S
CPH · DK · Healthcare · Diagnostics & Research · bioporto.com
1.225DKK-2.00%Mkt Cap: 90.14M $P/E: —

BioPorto A/S, an in-vitro diagnostics company, focuses on developing biomarker tests to help clinicians detect the kidney injury in critically ill patients at earlier stage in Denmark, rest of Europe, North America, and …

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1

Key Statistics

Company
Market Cap90.14M $
Enterprise Value83.24M $
Revenue (TTM)5.87M $
Gross Profit4.43M $
Net Income (TTM)-11.96M $
Revenue/Share0.0109 USD
Last Price1.225 DKK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees46
CountryDK
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-20.83
PEG—
EV/EBITDA-7.36
EV/Revenue14.19
P/S15.36
P/B9.84
EPS (TTM)-0.15
EPS (Forward)-0.06
52W Range
0.839059% of range1.488
52W High1.488 DKK
52W Low0.8390 DKK
Profitability
Gross Margin75.44%
Oper. Margin-107.49%
EBITDA Margin-192.72%
Profit Margin-203.83%
ROE-130.33%
ROA-88.13%
Growth
Revenue Growth47.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-11.22M $
CapEx (TTM)—
FCF Margin-114.23%
FCF Yield-7.44%
Net Debt-6.90M $
Net Debt/EBITDA0.61
Balance Sheet
Debt/Equity0.12
Current Ratio3.25
Quick Ratio2.81
Book Value/Sh0.1270 DKK
Cash/Share0.1110 DKK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 DKK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)1.750 DKK
Upside (mean)+42.9%
Target Range1.750 DKK – 1.750 DKK
# Analysts1
Ownership
Shares Out.495.10M
Float458.86M
Insiders29.80%
Institutions6.28%
Technical
SMA 501.146 (+6.9%)
SMA 2001.066 (+14.9%)
Beta1.38
S&P 52W Chg18.16%
Avg Vol (30d)298.86K
Avg Vol (10d)234.25K
Technical Indicators
RSI (14)61.1
MACD0.0201
MACD Signal0.0139
MACD Hist.+0.0062
BB Upper1.245 DKK
BB Middle1.188 DKK
BB Lower1.131 DKK
BB Width9.59%
ATR (14)0.0519 DKK
Vol Ratio (20d)2.57x